Predictors of short-term outcome in Chinese patients with ambulatory heart failure for heart transplantation with ejection fraction < 25%

Japanese Heart Journal

Volumn 41, Issue 3, 2000, Pages 349-369

  Huang, Chien Ming ^a,b   Young, Mason Shing ^a   Wei, Jeng ^a  

^a CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiomyopathy; Chinese patients; Heart failure; Heart transplantation

Indexed keywords

AMIODARONE; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; FUROSEMIDE; ISOPRENALINE;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ARTICLE; CHINESE; DYSPNEA; FEMALE; FOLLOW UP; HEART DILATATION; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PATIENT REFERRAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SUDDEN DEATH; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033879543     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.41.349     Document Type: Article

References (32)

1. Romeo F, Pelliccia F, Cianfrocca C, et al. Determinants of end-stage idopathic dilated cardiomyopathy: a multivariate analysis of 104 patients. Clin Cardiol 1989; 12: 387-92.
2. Stevenson LW, Tillish JH, Hamilton M, Luu M, Chelimsky-Fallick C, Moriguchi J, Kabashigawa J, Walden J. Importance of hemodynamic response to therapy in predicting survival with ejection < 20% secondary to ischemic or non-ischemic dilated cardiomyopathy. Am J Cardiol 1990; 66: 1348-54.
3. Unverferth D, Baker P. Value of endomyocardial biopsy. Am J Med 1986; 80 (suppl 2B): 22-32.
4. Shirey E, Proudfit W, Hawk W. Primary myocardial disease: correlation with clinical findings, angiographic and biopsy dale. Am Heart J 1980; 99: 198-207.
5. Cohn JN, Johnson GR, Shabeai R, Loeb H, Tristani F, Rector TS, Smith R, Fletcher R. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87: V15-16.
6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35.
7. Brophy JM, Deslauries G, Rouleau JL. Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol 1994; 10: 543-47.
8. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-86.
9. Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J: Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985; 55: 1037-42.
10. Baker BJ, Wilen MM, Boyd CM, Dinh H, Franciosa JA: Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. Am J Cardiol 1984; 54: 596-9.
11. Stevenson LW, Lacks H, Drinkwater DC, Kahan BD, Terasaki PI. Cardiac transplantation: selection, immunosuppression and survival. West J Med 1988; 149: 572-83.
12. Evans RW, Menninen DL, Garrison LP, Maier AM. Donor availability as the primary determinant of the future of heart transplantation. JAMA 1986; 255: 1892-8.
13. Huang CM, Young MS. Transradial approach for diagnosis of cardiovascular disease in Taiwanese patients: catheter selection, feasibility, complication and application. Acta Cardiol Sin 1999; 15: 9-16.
14. Hinkle LE, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982; 65: 457-63.
15. Franciosa JA, Wilen M, Ziesche S, Cohn JA. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 831-6.
16. Unverfeth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1984; 54: 147-52.
17. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987; 59: 634-8.
18. Wilson JR, Schwartz JS, St. John Sutton M, Ferraro N, Horowitz, LN, Reichek N, Josephson ME. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983; 2: 403-9.
19. Bocchi EA, Bellotti G, Moreira LF, et al. Mid-term results of heart transplantation, cardiomyopathy, and medical treatment of refractory heart failure caused by idiopathic dilated cardiomyopathy. J Heart Lung Transplant 1996; 15: 736-45.
20. Pelliccia F, d'Amati G, Cianfrocca C, Bernucci P, Nigri A, Marino B, Gallo P. Histomorphometric features predict 1-year outcome of patients with idiopathic dilated cardiomyopathy considered to be at low priority for cardiac transplantation. Am Heart J 1994; 128: 316-25.
21. Anguita M, Arzon JM, Bueno G, Latre JM, Sanchi M, Torres F, Gimenez D, Concha M, and Valles F. Clinical and hemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1993; 72: 413-7.
22. Dies F, Krell MJ, Whitlow P, Liang C, Goldenberg I, Applefeld MM, Gilbert EM. Intermittent dobutamine in ambulatory outpatients with chronic heart failure (abstract). Circulation 1986; 74 (suppl 2, pt 2): II-38.
23. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, Ritsch ME Jr, Stevenson LW. Twenty-fourth Bathesda conference: cardiac transplantation: Task Force 3: recipient guidelines/priorization. J Am Coll Cardiol. 1993; 22: 22-31.
24. Lampert S, Lown B, Graboys T, Podrid P, Blatt C. Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease. Am J Cardiol 1988; 61: 791-7.
25. Grayboys T, Lown B, Podrid P, DeSilva R. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol 1982; 50: 437-43.
26. Keogh AM, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or ischemic cardiomyopathy assessed for heart transplantation. Am J Cardiol 1990; 65: 903-8.
27. Clelend J, Dargie H, Ford I, Mortality in heart failure: clinical variables of prognostic value. Br Heart J 1987; 58: 572-82.
28. Wyse DG, Morganroth J, Hallstrom A. Analysis of early ventricular proarrhythmia in the Cardiac Arrhythmia Suppression Trial (CAST) (abstract). J Am Coll Cardiol 1992; 19: 77A.
29. Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy: Clinical, echocardiographic and hemodynamic correlations and prognostic implications. J Am Coll Cardiol 1993; 22: 808-15.
30. Cohn JN, Archibald DGA, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986; 314: 1547-52.
31. Furberg CD, Yusuf S. Effect of vasodilators on survival in chronic congestive heart failure. Am J Cardiol 1985; 55: 1110-2.
32. The SOLVD investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with left ventricular ejection fractions. N Engl J Med 1992; 327: 685-91.